Curative Biotechnology (OTCMKTS:CUBT) Stock Price Up 15,708.8% – Time to Buy?

Curative Biotechnology, Inc. (OTCMKTS:CUBT)’s stock price shot up 15,708.8% on Tuesday . The company traded as high as $1.59 and last traded at $1.0750. 7,248 shares were traded during trading, a decline of 93% from the average session volume of 108,175 shares. The stock had previously closed at $0.0068.

Curative Biotechnology Stock Performance

The firm’s 50 day moving average price is $0.03 and its two-hundred day moving average price is $0.01.

About Curative Biotechnology

Curative Biotechnology, Inc, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. The company has an agreement with Mid-Atlantic BioTherapeutics, Inc to develop the COVID-19 vaccine.